Clinical Trials Browser

Phase EARLY_PHASE1 × posaconazole × 90 days × Clear all

NCT04825275 2026-01-23

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Phase EARLY_PHASE1 Terminated

7 enrolled 12 charts

Brain Neoplasms, Glioblastoma